In the course of liquid culture, serial passage experiments with Escherichia coli K-12 bearing a mutator gene deletion (DmutS) we observed the evolution of strains that appeared to kill or inhibit the growth of the bacteria from where they were derived, their ancestors. We demonstrate that this inhibition occurs after the cells stop growing and requires physical contact between the evolved and ancestral bacteria. Thereby, it is referred to as stationary phase contact-dependent inhibition (SCDI ). The evolution of this antagonistic relationship is not anticipated from existing theory and experiments of competition in mass (liquid) culture. Nevertheless, it occurred in the same way (parallel evolution) in the eight independent serial transfer cultures, through different single base substitutions in a gene in the glycogen synthesis pathway, glgC. We demonstrate that the observed mutations in glgC, which codes for ADP-glucose pyrophosphorylase, are responsible for both the ability of the evolved bacteria to inhibit or kill their ancestors and their immunity to that inhibition or killing. We present evidence that without additional evolution, mutator genes, or known mutations in glgC, other strains of E. coli K-12 are also capable of SCDI or sensitive to this inhibition. We interpret this, in part, as support for the generality of SCDI and also as suggesting that the glgC mutations responsible for the SCDI, which evolved in our experiments, may suppress the action of one or more genes responsible for the sensitivity of E. coli to SCDI. Using numerical solutions to a mathematical model and in vitro experiments, we explore the population dynamics of SCDI and postulate the conditions responsible for its evolution in mass culture. We conclude with a brief discussion of the potential ecological significance of SCDI and its possible utility for the development of antimicrobial agents, which unlike existing antibiotics, can kill or inhibit the growth of bacteria that are not growing.
INTRODUCTION
When bacteria compete in liquid culture, the evolution of mutants that replicate faster on existing or by-product resources made available by the metabolism or death of other members of the community is anticipated and has been observed (Helling et al. 1987; Lenski et al. 1991; Zambrano & Kolter 1996; Farrell & Finkel 2003) . Not expected in these liquid (mass) culture conditions is the evolution of antagonistic relationships, mechanisms that enable bacteria to kill or inhibit the growth of competitors, like the production of bacteriocins or antibiotics. In the absence of spatial heterogeneity, all members of the community gain equally from the resources made available by the death or growth inhibition of other members. As a result, individual bacteria producing these allelopathic agents and engendering the cost of their production would not gain advantage that would enable them to increase in frequency when they are rare (Chao & Levin 1981; Levin 1988; Kerr et al. 2002) . Nevertheless, in broth cultures of Escherichia coli we observed the rapid evolution of mutants that appeared to inhibit the growth or kill the bacteria from where they were derived-their ancestors. This inhibition does not occur until these bacteria are at stationary phase, a time when they are refractory to other toxic agents like antibiotics (Bigger 1944; McDermott 1958; Levin & Rozen 2006) .
In this report, we examine the properties of this evolved antagonistic interaction, determine its genetic basis, explore its generality in other strains of E. coli and with the aid of a mathematical model explore the population dynamics of this process and the conditions responsible for its evolution. We conclude with a brief discussion of the potential ecological implications and practical applications of this phenomenon.
MATERIAL AND METHODS
In the following we describe some of the materials and methods used in this investigation. More information about these methods can be found in the electronic supplementary material.
(a) Culture medium Unless noted, bacterial strains were grown at 378C in LuriaBertani (LB) media (Miller 1972) or Kornberg (KB) media (1.1% K 2 HPO 4 , 0.85% KH 2 PO 4 , 0.6% yeast extract and 1% glucose).
(b) Sampling methods
Estimates of the densities of the bacterial cultures and the relative frequencies of the different populations were obtained by serial dilution and plating on LB agar, LB agar with streptomycin (100 mg ml K1 ), ampicillin (100 mg ml K1 ), chloramphenicol (25 mg ml K1 ) or tetracycline (10 mg ml
K1
). Tetrazolium arabinose (TA; Levin et al. 1977 ) agar or McConkey agar (DIFCO 1984) containing 1% arabinose was also used to estimate the relative frequencies of strains that differed by an arabinose marker. Unless otherwise noted, liquid cultures were in 50 ml Erlenmeyer flask containing LB (10 ml) and were maintained at 378C with shaking at between 150 and 250g.
(c) Bacteria AB1157. thr-1 leu-6 thi-1 lacY1 galK2 ara-14 xyl-5 mtl-1 proA2 his-4 argE3 str-31 tsx-33 supE44 rec C F-. AB1157DmutS::spc gyrA (a derivative of AB1157 provided by Ivan Matic). For convenience, we designate this most prominently used strain as ABM. We also used spontaneous Ara C revertants of this strain for mixed culture experiments. (e) Fluorescence-activated cell sorting analysis Discosoma red (DsRed)-labelled E. coli were obtained by transformation of ABM cells with plasmid pMW211; a colE1 derivative that expresses a DsRed variant protein and confers resistance to ampicillin (a kind gift from Dr Arthur Altenhoefer, University of Wuerzburg). Green fluorescent protein (GFP)-labelled E. coli were obtained following transformation of ABM cells with the multicopy plasmid pGFP (Amp R ), (a kind gift from S. Méresse, centre d'Immunologie de MarseilleLuminy). Flow cytometry was carried out using a Becton Dickinson fluorescence-activated cell sorting (FACS) Vintage SE instrument with a 70 mm sorting nozzle at low pressure (12 psi). GFP and DsRed were excited using a 488 nm blue laser and detected using 530/30 and 585/42 nm filters, respectively. DsRed-labelled ancestral ABM and GFP-labelled evolved ABM E. coli were prepared by overnight growth in LB broth supplemented with ampicillin (75 mg ml
). Mixed cultures (10 ml) initiated at a 10 : 1 ancestor-to-evolved ratio were incubated in 500 ml culture flasks at 378C with shaking at 250g for the times indicated (figure 3). Evolved-bound ancestor cells and free ancestor cells were isolated by sorting approximately 30 000 particles of each cell population into separate tubes containing phosphate-buffered saline (0.3 ml). Serial dilutions of the samples were plated on McConkey agar plates containing arabinose to discriminate between Ara K (evolved) and Ara C (ancestors) bacteria. For the control experiment shown in figure 3b ,d, the GFP-labelled ancestors were Ara K , to distinguish them from the DsRed-labelled Ara C ancestors. The viability of DsRed-ancestral cells was determined by counting colony-forming units per particle sorted from each gated population.
RESULTS (a) The phenomenon
The evolved antagonistic interaction reported here was an unanticipated (serendipitous) outcome of in vitro evolution experiments. Eight independent cultures of a mutator strain of E. coli K-12 AB1157DmutS::spc (Bregeon et al. 1999 ; here referred to as ABM) were maintained in 50 ml flasks by daily transfer (100 ml-10 ml) in LB broth. After 62 passages (approx. 412 generations), 50 ml of overnight cultures derived from single colonies from 'evolved' cultures were mixed in 10 ml LB with 50ml of ABM and grown together for 24 hours. For all eight cultures, the density (CFUs) of the ancestral cells after 24 hours of growth was less than 10 K3 that of the evolved. This rapid decline in the density of the ancestral cells did not occur when these bacteria were in single clone culture, and in mixed culture it only occurred after the populations stopped growing ( figure 1a,b) . The details of the methods for this and the other experiments reported here and more information about the phenomenon can be found in the §2 and in the electronic supplementary material.
This precipitous decline in the density of the ancestral bacteria also occurs when ancestral cells are mixed at stationary phase with evolved bacteria from any of the eight independent serial transfer cultures or after stationary phase when they are grown together. This inhibition or killing does not occur when evolved cells from independent cultures are mixed with each other (data not shown). Moreover, this apparent killing of the ancestral cells by evolved is frequency and density dependent; it does not occur when the frequency of the evolved cells in the mixture is low or when the total density of bacteria in sterile filtrates of stationary phase cells is less than approximately 5!10 7 (figure 2).
(b) Killing or inhibition? Because the preceding results are based on colony counts, it is possible that in the liquid cultures being sampled the ancestral cells were viable, but their ability to form colonies was inhibited by the evolved cells upon entry into the stationary phase of growth. To ascertain whether this is the case or if the ancestral cells are in fact killed, we tested for the selective inclusion of propidium iodide (PI ), which does not occur in viable cells (Boulos et al. 1999) . The ancestral ABM cells do not selectively include PI in the mixed stationary phase cultures with evolved (see figure S9 and more detailed information in the electronic supplementary material). Thus, we cannot conclude that the ancestral bacteria are killed by the evolved, but may well be converted to a viable but not culturable (VBNC) state (see §4). For this reason, we shall refer to this phenomenon as inhibition rather than killing.
(c) Stationary phase contact-dependent inhibition In theory (the results of mathematical modelling studies), the observed frequency-and density-dependent inhibition of ancestral bacteria by evolved can be attributed to either the evolved bacteria releasing extracellular toxins, allelopathic agents that inhibit the ancestral bacteria, or inhibition through physical contact with the evolved bacteria (Levin 1988 ; electronic supplementary material, figure S13 ).
Two lines of evidence support the hypothesis that the observed inhibition cannot be attributed to extracellular toxins: (i) the rate of decline in the density of ancestral cells in filtrates of stationary phase cultures of evolved cells or mixtures of evolved and ancestral cells is no different than that in filtrates of their own cells (electronic supplementary material, figure S1 ) and (ii) the density of ancestral cells does not decline at this accelerated rate when they are separated from the evolved bacteria by 0.45 mm filters in 'U-tube' experiments (electronic supplementary material, figure S2 ).
The above experiments, however, do not formally rule out inhibition by a highly labile, secreted allelopathic agent and are therefore only suggestive of a contact-dependent mechanism. Direct evidence that this inhibition involves contact of ancestral bacteria with the evolved comes from FACS experiments (Aoki et al. 2005) . Evolved ABM were labelled with the GFP and the ancestral ABM with the DsRed fluorescent protein and grown together in LB. Three different bacterial populations were observed: free green evolved cells; free red ancestral cells; and aggregates of evolved and ancestral cells (figure 3a). This aggregation also occurred in control cultures with mixtures of DsRed-and GFP-labelled ancestral cells (figure 3b). The viability of the free ancestral cells was compared (from CFU data) with that of the clustered, evolved-bound ancestors following FACS of mixed cultures of evolved and ancestral bacteria. The results indicated that the evolved-bound ancestors declined at a faster rate than their unbound counterparts following the onset of stationary phase contact-dependent inhibition (SCDI; figure 3c). A lesser but significant decline in the density of recovered free ancestral cells was also observed in these experiments. We attribute this to their release (dissociation) from the aggregates with evolved as a result of agitation during sampling. Consistent with this interpretation is the observation that there was no loss of viability in control cultures with mixtures of GFP-and DsRed-labelled ancestral cells (figure 3d ).
(d) SCDI in other E. coli strains To begin to explore the generality of the SCDI phenomenon, we grew mixtures of overnight LB cultures of the evolved and the ancestral ABM with five different stocks of E. coli K-12 and a strain of E. coli B. (i) The evolved ABM inhibited the AB1157 mutSC from where they were derived and two of its derivatives (AB1157-D and JC5129) and an E. coli K-12 strain, MC1061, which has a different genetic ancestry than AB1167. (ii) The ancestral ABM as well as AB1157 mutSC are inhibited at stationary phase when they are mixed with the E. coli K-12 strains MG1655 and C600 and a wild-type E. coli B (electronic supplementary material, figures S13 and S14). In all of these cases, inhibition does not occur until after the bacteria are at stationary phase nor does it occur when the inhibited strain is in sterile supernatants of the challenging E. coli. Finally, the replication of the evolved ABM is not inhibited when it is mixed with either MG1655, C600 or E. coli B, despite the ability of these bacteria to inhibit its unevolved ancestor.
(e) The genetic basis of SCDI As a first attempt to identify the gene(s) responsible for the observed SCDI, we took a genetic approach that was based on the assumption that the alleles which evolved in the serial passage, evolution experiments with ABM would Evolution of antagonism in E. coli M. Lemonnier et al. 5
be dominant (details in the electronic supplementary material). We found that in this evolved ABM, SCDI can be attributed to single base substitution mutations in glgC, which encodes ADP-glucose pyrophosphorylase, a regulatory enzyme that catalyses the first reaction of bacterial glycogen synthesis (Ballicora et al. 2003) . The details of the procedures used to identify this gene and demonstrate that it is responsible for both the immunity of the evolved strains to killing and their ability to kill the ancestral strain are presented in the electronic supplementary material. In summary: (i) a shotgun library of genomic DNA from an evolved 62nd transfer clone was constructed with a mini-F plasmid which was used to transform the ancestral ABM. (ii) Independent transformants were pooled, mixed with evolved cells and passaged twice to enrich for bacteria carrying potential genes for immunity to SCDI. (iii) The mini-F plasmid pCDI1 of the pSCDI-refractory clone obtained contained the glgCAP operon for glycogen synthesis which bore a glgC allele that differed from the ancestral glgC by a C to T transition in the 17th codon (proline to serine; figure 4a). (iv) This mutation, glgC17, was cloned in a multicopy pBR322 plasmid, pMLM141. (v) Both the pMLM141 transformants of the ancestral AB1157 DmutS, and the original evolved strain produced high concentrations of glycogen as measured by iodine staining, while the ancestral cell line and the evolved strains deleted for the chromosomal glgC17 produced little or no glycogen (figure 4b). (vi) Ancestral cell transformants bearing pMLM141 were not inhibited by the evolved strain while those bearing pBR322 without the glgC17 were (figure 4c). (vii) Ancestral cells carrying pMLM141 inhibited those bearing pBR322 without glgC17 as well as evolved cells that were deleted for glgC17 (figure 4d ).
Our results indicate that evolution of SCDI in the eight serial passage cultures occurred independently but was convergent phenotypically as well as genetically. Although the extent varied among the eight independently evolved SCDI strains, all overproduced glycogen relative to the ancestral strain as well as to an E. coli K-12 MG1655 control (data not shown). Furthermore, all eight evolved SCDI strains bore single non-synonymous base substitutions in glgC; two in the 17th codon and one each in the 14th, 66th, 125th, 318th, 330th and 336th codons (electronic supplementary material, table 1).
A biochemical clue to the reason for the high glycogen phenotype of these mutants is provided by the finding that the G336D glgC mutation increases enzymatic activity and alters the allosteric behaviour of ADP-glucose pyrophosphorylase (Ballicora et al. 2003) . This overproduction of glycogen appears to be necessary for the inhibition of ancestral cells. AB1157 glgC17 mutants deleted for glgA (glycogen synthase), that no longer synthesize glycogen, do not cause SCDI when mixed with ancestral ABM (electronic supplementary material, figure S8 ). On the other hand, inactivation of glgP had no impact on SCDI. This gene encodes glycogen phosphorylase, the major exolytic enzyme of glycogen catabolism Alonso-Casajú s et al. 2006, which removes glucosyl units from the nonreducing ends of the polymer (electronic supplementary material, figure S8 ). This suggests that glycogen catabolism may not be required for SCDI.
While it is clear that glgC mutations are responsible for evolved SCDI in ABM, our results suggest that these mutations are most probably suppressors that compensate for defects in ABM. AB1157 and MC1061 and possibly other strains may have similar or identical defects that make them susceptible to SCDI. The DNA sequences of glgC in MG1655 and the ancestral ABM as well as AB1157 are identical (data not shown). Thus, mutations in glgC are not necessary for SCDI by MG1655. The genetic basis for these defects awaits further elucidation before any plausible mechanistic model for SCDI can be proposed.
(f ) Population and evolutionary dynamics of SCDI As noted in §1, the evolution of an antagonistic interaction such as SCDI in liquid (mass) culture is inconsistent with the proposition that mechanisms to kill or inhibit the growth of competitors will not evolve under these conditions (Chao & Levin 1981; Levin 1988; Frank 1994; Kerr et al. 2002) . In accordance with this theory and these experiments, if there is a cost in the fitness of the evolved SCDI strain associated with its ability to inhibit the growth or kill the ancestral strain, when rare SCDI mutants should not be able to increase to frequencies where they would be detected. To illustrate this and other properties of the population dynamics of SCDI, we used numerical solutions to the differential equations of a simple mathematical model, a computer simulation. In this model we consider a serial transfer, liquid culture populations of the sort used in our evolution experiments with 1/100 dilutions into fresh medium occurring every 24 hours. We assume a mass action process so that interaction between the ancestral and evolved bacteria occurs at a rate proportional to the product of their densities. In this model, ancestral cells are killed instantly upon contact with evolved and this contact-dependent killing does not start until 16 hours after the populations starts to grow, when the bacteria when the culture would If SCDI engenders a 1% cost in the exponential growth rate, evolved cells continue to be present, due to recurrent mutation, but their population does not increase in frequency, despite the SCDI advantage ( figure 5A ). If the ability to inhibit ancestral cells engenders no cost or benefit to the density-and frequency-independent fitness of the evolved bacteria, then as a consequence of SCDI the density of the evolved population increases at a rate which itself increases with the density of the evolved cells ( figure 5B ). However, if SCDI is the only advantage possessed by the evolved bacteria, their rate of ascent will be low and they would probably not have been detected, much less dominated the population by the 62nd transfer (as we observed). On the other hand, if in addition to SCDI the ancestral bacteria had a higher rate of mortality than the evolved, the frequency of the evolved would increase due to the combination of this density-independent fitness advantage and the density/frequency-dependent advantage resulting from SCDI ( figure 5C ). As can be seen in the electronic supplementary material, in single clone culture the evolved bacteria in fact die at a lower rate than the ancestral strain (electronic supplementary material; figure 4).
DISCUSSION
The observation that initiated this investigation was serendipitous. Based on existing theory and observations (Chao & Levin 1981; Levin 1988; Frank 1994; Kerr et al. 2002) , the evolution in mass (liquid) culture of bacteria that inhibit the growth or kill the cells from where they are derived, their ancestors, would not have been anticipated or sought. However, in retrospect, the observation that contact-dependent inhibition (CDI ), SCDI, evolved independently by different mutations in the same gene in eight cultures of a mutator strain of E. coli is an excellent and novel, but not at all surprising, example of parallel evolution. For other examples of parallel changes occurring in independent experimental populations of bacteria derived from the same ancestor lineage, see Cunningham et al. (1997) , Wichman et al. (1999 Wichman et al. ( , 2000 Wichman et al. ( , 2005 , Cooper et al. (2003) , Crozat et al. (2005) , Sachs & Bull (2005) , Woods et al. (2006) and Bantinaki et al. (2007) .
Owing to a yet unknown mutation or a pleiotropic effect of a known mutation in the course of its long existence in laboratory culture, the mutSC AB1157 strain of E. coli K-12 may have become sensitive to CDI at stationary phase by at least some other strains of E. coli including other K-12 derivatives (MG1655, C600 as well as the glgC mutants that evolved in these experiments). This sensitivity was maintained in the mutator construct of AB1157, DmutS::spc (Bregeon et al. 1999) used in the evolution experiments where this phenomenon was first observed. In the course of these experiments, missense mutations were generated in glgC that both suppressed the sensitivity of these bacteria to CDI during the stationary phase these serial transfer experiments and permitted these bacteria to inhibit the ancestral strain.
Although we have not formally demonstrated it, by moving the glgC mutant genes responsible for SCDI to separate AB1157 backgrounds, our results and parsimony suggest that these glgC mutations also provided ABM with a density-and frequency-independent fitness advantage by reducing their rate of mortality. As a consequence of the latter, these glgC mutations were able to increase in frequency when they were rare and achieve densities where they had the additional advantage of inhibiting/killing the dominant population with wild-type glgC loci. The primary, if not exclusive, role of the mutS gene in this process was to increase the rate at which the suppressing glgC mutations occurred, which in addition to providing the variation needed for this evolution, reduced the likelihood of their loss in the bottlenecks associated with serial passage (Levin et al. 2000) . Presumably SCDI would eventually evolve if mutSC strains of AB1157 or other strains with this sensitivity were maintained long enough in serial transfer cultures of this type.
In some ways, the SCDI that evolved in these experiments is similar to the growth advantage in stationary-phase (GASP) phenomenon studied by Kolter and colleagues (Zambrano & Kolter 1996; Farrell & Finkel 2003) ; it too is manifest at stationary phase and requires high pH (greater than 8.5; electronic supplementary material, figure S5 ). SCDI is, however, clearly different from GASP both functionally and genetically. (i) The decline in plating efficiency of ancestral cells when mixed with evolved (figure 1b) occurs at a rate nearly ten times as great as the highest reported for GASP (Zambrano & Kolter 1996) . (ii) Contrary to what would be anticipated by the scavenging mechanism (differential use of resources made available from dead cells) postulated for GASP, there was little or no growth of evolved cells when they were inoculated at low densities into filtrates of stationary phase ancestral cells or filtrates of sonicated ancestral cells (data not shown). (iii) The lrp and rpoS mutations that account for GASP are not present in the evolved ABM, nor in their ancestors ABM and AB1157 (data not shown).
The underlying mechanisms by which cells are inhibited in the SCDI reported here and the CDI reported by Aoki et al. (2005) have not yet been elucidated. However, it is clear that these two inhibitory processes are functionally and genetically distinct. CDI of E. coli K-12 (MG1655) by a naturally occurring strain of E. coli from a urinary tract infection occurred when the bacteria were growing, rather than at stationary phase. Moreover, the cdiA and cdiB genes that were found to be responsible for CDI by the wild E. coli are not present in E. coli K-12, wherein SCDI evolved in the present study.
In this report we use the term 'inhibition' rather than 'killing' in our description of the observed SCDI because the results of the PI test suggested that the ancestral bacteria are VBNC, when mixed with the evolved cells at stationary phase. It should be noted, however, that the concept of VBNC bacteria is controversial; whether these cells are dormant or are progressively undergoing cell death is unclear ( Nystrom 2003; Oliver 2005) . What is clear from our studies is that the decline in the density of the inhibited strain in these cultures cannot be attributed to their failure to form colonies on agar. Their densities continue to decline in successive serial passages (electronic supplementary material, figure S10).
The mechanism by which the glgC mutations that evolved in these experiments convert the ancestral strain into an inhibitor requires further research. Excessive glycogen synthesis, the apparent phenotype derived from the glgC mutants, could trigger the inhibitory function. Glycogen excess mutations of E. coli have been mapped to the glgC gene encoding ADP-glucose pyrophosphorylase, a regulatory enzyme for bacterial glycogen synthesis (Ballicora et al. 2003 and references therein). In particular, certain amino acid substitutions of GlgC are known to alter the allosteric behaviour of the protein and increase glycogen synthesis (Meyer et al. 1993; Wu & Preiss 1998) . However, to the best of our knowledge there is no evidence that glycogen synthesis is correlated with any known bactericidal activity. In solution, glycogen is devoid of antimicrobial activity (data not shown). High glycogen accumulation might alter the cell structure, leading to effects involved in killing. Indeed, evolved hyperglycogenic strains are more susceptible than the ancestors to SDS 0.2% (data not shown), suggesting possible alterations of the bacterial cell envelope. We cannot discount at the present time that the excess glycogen synthesis may be related to oxidative or other envelope stress pathways. Hence, our report here of the SCDI phenomenon in E. coli populations sets the basis for future research towards the precise mechanism of SCDI in this and eventually other bacteria.
How important the CDI reported by Aoki et al. (2005) and that observed in this study are to the ecology of bacteria is unclear at this time but is certainly intriguing and worthy of further investigation. If in natural populations CDI and SCDI have effects of the magnitude observed in these laboratory studies, they could have a profound effect on the structure of bacterial communities. CDI could facilitate the invasion of strains into habitats occupied by other members of their species and lead to the elimination of these competitors. From a medical perspective CDI may well point to as yet unexploited chinks in the bacterial armour. By elucidating the mechanisms responsible for the sensitivity of E. coli K-12 to SCDI, new targets for antimicrobial agents could be identified. Most if not all classic and contemporary antibiotics have little effect on bacteria that are not replicating (Bigger 1944; McDermott 1958; Levin & Rozen 2006) . In practice (Eagle 1952; McDermott 1958; Tuomanen 1986 ) as well as in theory (Levin 2004; Wiuff et al. 2005; Levin & Rozen 2006) tolerant, persistent and latent populations of non-replicating, antibiotic-refractory bacteria can extend the term of treatment as well as lead to treatment failure. The mechanism responsible for the SCDI reported here is particularly appealing because the inhibition or killing occurs when the bacteria are not replicating.
